B
FMS icon

Bailard’s Fresenius Medical Care FMS Stock Holding History

Bailard’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,789
Closed -$415K – 758
2021
Q4 		$415K Sell
12,789
-4,630
-27% -$152K 0.01% 440
2021
Q3 		$609K Sell
17,419
-444
-2% -$17.3K 0.02% 371
2021
Q2 		$743K Buy
17,863
+1,451
+9% +$58K 0.03% 321
2021
Q1 		$605K Buy
16,412
+2,336
+17% +$88.3K 0.02% 352
2020
Q4 		$585K Buy
14,076
+2,000
+17% +$83.4K 0.03% 293
2020
Q3 		$513K Buy
12,076
+756
+7% +$32.6K 0.03% 276
2020
Q2 		$490K Buy
11,320
+422
+4% +$16.7K 0.03% 272
2020
Q1 		$357K Buy
10,898
+4,858
+80% +$181K 0.03% 281
2019
Q4 		$222K Buy
+6,040
New +$214K 0.01% 473
2019
Q3 		– Sell
-6,035
Closed -$237K – 551
2019
Q2 		$237K Buy
+6,035
New +$239K 0.01% 463

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bailard's FMS Position: Q1 2022 in Review

Bailard sold out of Fresenius Medical Care (FMS) in Q1 2022, closing a stake of 12,789 shares — an estimated $415K sold.

Bailard first reported a position in FMS in Q2 2019 and held it in 10 quarters. The position peaked at $743K in Q2 2021. 178 funds tracked by Wall St. Rank hold FMS as of Q1 2022.

  • Bailard reported no remaining Fresenius Medical Care position as of Q1 2022 after selling out during the quarter.
  • Bailard sold 12,789 Fresenius Medical Care shares in Q1 2022, an estimated $415K.
  • Bailard first reported a position in Fresenius Medical Care in Q2 2019 and held it in 10 quarters.
  • Bailard's Fresenius Medical Care position peaked at $743K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2022.

Based on Bailard's 13F filing for Q1 2022, filed 25 Apr 2022.